Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$782K Sell
2,158
-71
-3% -$24.3K 0.08% 133
2026
Q1
$784K Buy
2,229
+413
+23% +$147K 0.1% 115
2025
Q4
$595K Buy
1,816
+151
+9% +$47.9K 0.08% 145
2025
Q3
$470K Buy
1,665
+162
+11% +$47K 0.07% 181
2025
Q2
$440K Buy
+1,503
New +$426K 0.07% 176

Other funds holding AMGN

FSM Wealth Advisors's AMGN Position: Q2 2026 in Review

FSM Wealth Advisors reduced its Amgen (AMGN) stake by 3.2% in Q2 2026, selling an estimated $24.3K and leaving 2,158 shares worth $782K. The position accounts for 0.08% of the portfolio, ranked #133.

FSM Wealth Advisors first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $784K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • FSM Wealth Advisors held 2,158 shares of Amgen worth $782K as of Q2 2026.
  • FSM Wealth Advisors sold 71 Amgen shares in Q2 2026, an estimated $24.3K.
  • Amgen made up 0.08% of FSM Wealth Advisors's portfolio in Q2 2026, its #133 holding.
  • FSM Wealth Advisors first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • FSM Wealth Advisors's Amgen position peaked at $784K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.